Jay P. Shepard's most recent trade in Esperion Therapeutics Inc. was a trade of 164,472 Common Stock done . Disclosure was reported to the exchange on July 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Jul 2026 | 164,472 | 0 (0%) | 0% | - | Common Stock | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Jul 2026 | 44,000 | 0 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Jul 2026 | 32,500 | 0 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Jul 2026 | 21,000 | 0 | - | - | Stock Option (right to buy) | |
| Ironwood Pharma Inc (Class A) | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 63,481 | 235,036 (0%) | 0% | 0 | Class A Common Stock | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2026 | 79,873 | 164,472 (0%) | 0% | 0 | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 41,800 | 41,800 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 34,200 | 34,200 | - | - | Restricted Stock Unit | |
| Ironwood Pharma Inc (Class A) | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 45,000 | 171,555 (0%) | 0% | 0 | Class A Common Stock | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 33,000 | 84,599 (0%) | 0% | 0 | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 9,209 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 0 | - | - | Restricted Stock Unit | |
| Ironwood Pharma Inc (Class A) | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,311 | 126,555 (0%) | 0% | 0 | Class A Common Stock | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 23,000 | 51,599 (0%) | 0% | 0 | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 7,042 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
| Ironwood Pharma Inc (Class A) | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 22,350 | 102,244 (0%) | 0% | 0 | Class A Common Stock | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,150 | 28,599 (0%) | 0% | 0 | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 58,521 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 4,273 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 4,273 | 39,521 (0%) | 0% | - | Common Stock | |
| Ironwood Pharma Inc (Class A) | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 21,571 | 79,894 (0%) | 0% | 0 | Class A Common Stock | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 35,248 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 4,274 | 17,248 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Jay P. Shepard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 4,274 | 4,273 | - | - | Restricted Stock Unit |